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Introduction
Renal cell carcinoma (RCC) is the most common
cancer associated with the kidney. RCC accounts for
approximately 3% of all adult malignancies with the
incidence increasing by almost 2% per year. 1,2 Radical
nephrectomy is the standard of treatment for patients
with localized disease; however approximately 30% of
patients present with metastasis.2
The use of radiation therapy is most often limited
to post-operative cases when residual tumor is
identified or for symptomatic relief of metastatic
disease. Definitive radiation treatment is not
commonly indicated due to the low tolerance to
radiation of surrounding abdominal structures such as
the small bowel, ipsilateral kidney, and spinal cord.
For patients diagnosed with left-sided RCC, the main
dose limiting structure is the small bowel. The
following case study will focus on avoiding bowel
toxicity with the use of post-operative radiation
therapy for the treatment of a Stage III left-sided renal
cell carcinoma.
Bowel Toxicity
Normal tissue tolerance doses to radiation often
limit the curability of a malignancy. A tumor lethal dose
of radiation cannot be delivered when a critical
structure, such as the small bowel, is included in the
treatment field.
Small bowel radiation toxicity is characterized by
mucosal inflammation and breakdown. Chronic injury
includes the development of progressive vascular
stenosis and intestinal wall fibrosis.3 Acute and chronic
toxicities associated with irradiation of the small bowel
are listed in Table 1.3,4
The two most important factors influencing
radiation toxicity to the small bowel are the total dose
of radiation received and the volume of bowel in the
field. Complication rates for critical structures are
identified in terms of TD5/5. This represents the Tissue
Dose associated with a 5% injury rate within 5 years of
radiation treatment. The TD5/5 doses for the small bowel
are 4500cGy for approximately 400cm2 of bowel and
5000cGy when 100cm2 of bowel is included in the
treatment field.5 This correlation shows the importance
of conformal radiation techniques.
Acute Effects
(6-18 months post RT)
Diarrhea

Figure 1. Supine computer plan.

Dose Comparison
On the Supine computer plan, a large volume of small bowel
is receiving 80% to 102% of the prescribed dose. This would
well exceed the TD5/5 limitation.
According to the Decubitus plan, the volume of small bowel
included in the field was much less than the supine and the
dose was limited to approximately 80% or 4320cGy.

Case Description
This case involves a 47-year-old white male who
presented with left flank pain, hematuria, and a topical
abdominal mass. Computed tomography (CT) revealed
a large mass in the left kidney. The patient underwent
a left sided nephrectomy which demonstrated clear
renal cell carcinoma with sarcomatoid and rhabdoid
differentiation. Surgical margins were clear with the
exception of evidence of cancerous cells within the
actual renal vein. The patient was staged as T3b, NX,
M0.
Radiation therapy was recommended. The patient
initially underwent CT simulation in the supine position
(Figure 1). A significant amount of bowel was noted in
the proposed treatment plan. The patient was then
repositioned and a CT simulation in the right lateral
decubitus position was performed (Figure 2).
The prescription dictated a dose of 4500cGy be
delivered at 180cGy/fraction for 25 fractions. A boost
field was planned to a dose of 900cGy in 5 fractions for
a cumulative dose of 5400cGy. Both fields utilized 23
MV photons.

Conclusion
The standard of care for RCC is surgery; however,
with modern treatment techniques and adaptation of
dose and treatment volume, complication rates are
considerably lower than 5-10% in daily practice and
comparable to major abdominal surgery alone.3
Clinical trials including systemic biological agents
are underway for the treatment of RCC.1 These
innovative approaches may aid in reducing the need for
radiation therapy for advanced RCC and the possible
toxicities associated with it to the small bowel.

1.

Chronic Effects
(18 months- 5 years post RT)
Bowl Obstruction

2.
3.

Colicky Abdominal Pain Fistula Formation

4.

Nausea

Perforation

5.

Vomiting

Hemorrhage

Table 1.3,4 Possible side effects associated with radiation to the abdomen

Figure 2. Lt. Lat. Decubitus computer plan.
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